{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:14:16Z","timestamp":1762542856703,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jcte.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:44:55Z","timestamp":1527169495000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Influence of peroxisome proliferator-activated receptor-\u03b3 exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"13","author":[{"given":"Annalisa","family":"Giandalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Angela","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina T.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta L.","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Alibrandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Di Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5977-3062","authenticated-orcid":false,"given":"Roberto","family":"Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Cucinotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2018.05.002_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"ESHRE\/ASRM Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jcte.2018.05.002_b0010","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.05.002_b0015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jcte.2018.05.002_b0020","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.05.002_b0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Metabol"},{"key":"10.1016\/j.jcte.2018.05.002_b0030","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2018.05.002_b0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1380269","article-title":"Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"138","author":"Diamanti-Kandarakis","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2018.05.002_b0040","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1210\/jc.2004-1006","article-title":"Beta-Cell function: a key pathological determinant in polycystic ovary syndrome","volume":"90","author":"Goodarzi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.05.002_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.fertnstert.2016.04.040","article-title":"Genetic determinants of polycystic ovary syndrome: progress and future directions","volume":"106","author":"Jones","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jcte.2018.05.002_b0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0030-1249020","article-title":"Very high frequency of the polymorphism for the insulin receptor substrate 1 (IRS-1) at codon 972 (glycine972arginine) in Southern Italian women with polycystic ovary syndrome","volume":"42","author":"Pappalardo","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jcte.2018.05.002_b0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40618-016-0569-7","article-title":"Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome","volume":"40","author":"Pappalardo","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jcte.2018.05.002_b0060","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1210\/jc.2003-030322","article-title":"Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients","volume":"88","author":"Gonzalez","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.05.002_b0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2265.2005.02261.x","article-title":"The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome","volume":"62","author":"Hahn","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2018.05.002_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000279309","article-title":"Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome","volume":"70","author":"Chae","year":"2010","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jcte.2018.05.002_b0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1749-6632.2010.05647.x","article-title":"Peroxisome proliferator-activated receptor-gamma and -delta polymorphisms in women with polycystic ovary syndrome","volume":"1205","author":"Christopoulos","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcte.2018.05.002_b0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.gene.2012.04.060","article-title":"Polymorphisms in the IRS-1 and PPAR-\u03b3 genes and their association with polycystic ovary syndrome among South Indian women","volume":"503","author":"Dasgupta","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.jcte.2018.05.002_b0085","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.05.002_b0090","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2004-0109","article-title":"Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.05.002_b0095","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2003-031252","article-title":"Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity","volume":"89","author":"San Millan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2018.05.002_b0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1530\/EJE-08-1014","article-title":"Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome","volume":"161","author":"Koika","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2018.05.002_b0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF03401274","article-title":"The Pro12Ala polymorphism of the PPAR-gamma gene is not associated with the polycystic ovary syndrome","volume":"8","author":"Xita","year":"2009","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.jcte.2018.05.002_b0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1055\/s-2008-1058085","article-title":"Increased low grade inflammatory serum markers in patients with Polycystic ovary syndrome (PCOS) and their relationship to PPARgamma gene variants","volume":"116","author":"Knebel","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jcte.2018.05.002_b0115","first-page":"426","article-title":"Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome","volume":"82","author":"Bidzinska-Speichert","year":"2011","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.jcte.2018.05.002_b0120","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.fertnstert.2005.10.047","article-title":"Polymorphisms of the peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha genes in Chinese women with polycystic ovary syndrome","volume":"85","author":"Wang","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jcte.2018.05.002_b0125","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/humrep\/deh769","article-title":"Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype","volume":"20","author":"Tok","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jcte.2018.05.002_b0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/humrep\/deg128","article-title":"Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome","volume":"18","author":"Korhonen","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jcte.2018.05.002_b0135","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/09513590600733357","article-title":"Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome","volume":"22","author":"Yilmaz","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jcte.2018.05.002_b0140","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10815-013-0025-y","article-title":"Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome","volume":"30","author":"Shaikh","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.jcte.2018.05.002_b0145","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10815-012-9772-4","article-title":"A meta-analysis on the association between PPAR-\u03b3 Pro12Ala polymorphism and polycystic ovary syndrome","volume":"29","author":"He","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.jcte.2018.05.002_b0150","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.fertnstert.2006.10.006","article-title":"Genetic variant in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome","volume":"87","author":"Antoine","year":"2007","journal-title":"Fertil Steril"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221462371830022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221462371830022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:55:01Z","timestamp":1762005301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221462371830022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":30,"alternative-id":["S221462371830022X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2018.05.002","relation":{},"ISSN":["2214-6237"],"issn-type":[{"type":"print","value":"2214-6237"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of peroxisome proliferator-activated receptor-\u03b3 exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}